The US Food and Drug Administration has approved dalteparin sodium (Fragmin; Pfizer) as the first anticoagulant indicated for use in pediatric patients older than 1 month to reduce the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback